Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$17,500.00

Does ß-hexosaminidase play a significant role in hyaluronan degradation?

EF 2009-10

Résumé
Hyaluronan (HA) is a large carbohydrate made up of many sugar units. It is a member of a family of carbohydrates called glycosaminoglycans (GAGs). HA is abundant within the body and has its highest levels in connective tissues such as skin and cartilage. HA provides structural support at the cell and tissue level. It is also involved in cell to cell communication, joint lubrication, and inflammation. When removed from the body, HA is first broken down into short fragments through the action of enzymes called hyaluronidases. It is possible that short fragments of HA are broken down further through the action of ß-glucuronidase and ß-hexosaminidase, enzymes that degrade the HA fragments to one sugar units which can be recycled and re-used in a cell. To date, accumulation of HA has not been detected in hyaluronidase-deficient mice suggesting that other enzymes may play a bigger role in HA breakdown. Previous studies using ß-hexosaminidase-deficient mice revealed the accumulation of lipid (fat) and carbohydrate, including GAGs. The accumulating GAGs have not been fully identified and could include HA. This poses an important question, could ß-hexosaminidase play a significant role in the breakdown of HA? To answer this question, mice deficient in ß-hexosaminidase will be used to determine if the enzyme is required for the breakdown of HA. Mouse tissues from ß-hexosaminidase-deficient mice will be compared to mouse tissues from mice with the functioning enzyme. If HA is accumulating this suggests that ß-hexosaminidase does play a significant role in the breakdown of HA. If no accumulation is found in the mouse tissues, further studies will be done to check if other enzymes are doing the job for ß-hexosaminidase. Better understanding of the breakdown pathway of HA will allow for advanced research in diseases of the connective tissue such as osteoarthritis. The development of HA-based products and medical devices will also benefit from these types of studies.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
199621
Name
Gushulak Lara E
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Does ß-hexosaminidase play a significant role in hyaluronan degradation?
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Degradation Pathway Characterization; Exoglycosidases; Genotyping; Glycosaminoglycans; Histological Studies; Hyaluronan; Mouse Model Of Disease; Mucopolysaccharidosis
Abstract
Hyaluronan (HA) is a large carbohydrate made up of many sugar units. It is a member of a family of carbohydrates called glycosaminoglycans (GAGs). HA is abundant within the body and has its highest levels in connective tissues such as skin and cartilage. HA provides structural support at the cell and tissue level. It is also involved in cell to cell communication, joint lubrication, and inflammation. When removed from the body, HA is first broken down into short fragments through the action of enzymes called hyaluronidases. It is possible that short fragments of HA are broken down further through the action of ß-glucuronidase and ß-hexosaminidase, enzymes that degrade the HA fragments to one sugar units which can be recycled and re-used in a cell. To date, accumulation of HA has not been detected in hyaluronidase-deficient mice suggesting that other enzymes may play a bigger role in HA breakdown. Previous studies using ß-hexosaminidase-deficient mice revealed the accumulation of lipid (fat) and carbohydrate, including GAGs. The accumulating GAGs have not been fully identified and could include HA. This poses an important question, could ß-hexosaminidase play a significant role in the breakdown of HA? To answer this question, mice deficient in ß-hexosaminidase will be used to determine if the enzyme is required for the breakdown of HA. Mouse tissues from ß-hexosaminidase-deficient mice will be compared to mouse tissues from mice with the functioning enzyme. If HA is accumulating this suggests that ß-hexosaminidase does play a significant role in the breakdown of HA. If no accumulation is found in the mouse tissues, further studies will be done to check if other enzymes are doing the job for ß-hexosaminidase. Better understanding of the breakdown pathway of HA will allow for advanced research in diseases of the connective tissue such as osteoarthritis. The development of HA-based products and medical devices will also benefit from these types of studies.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gushulak, Lara E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~